Identifying and Converting Co-Promotion Opportunities in the Pharmaceutical Industry.
This report was developed to research pharmaceutical co-promotions - and what makes them successful. Pharmaceutical Co-Promotion Management examines the inner workings of pharmaceutical co-promotions. From overall budgets and control to in the field strategies and tactics, this report details the inner workings of some of the industry's top companies' co-promotions.
Pharmaceutical Co-Promotion Management analyzes co-promotion practices from some of the industry's top companies to provide all the steps necessary to build stronger, more successful co-promotions. From identifying and winning potential deals to structuring oversight to establishing in the field communication links, the report provides co-promotion leaders the tools to improve their efforts. Spending, staffing, structure and strategies of top pharmaceutical companies' co-promotions offers purchasers benchmarks for excellence.
The report makes its case with metrics and techniques for managing co-promotions:
--Investment and Structure - Overall co-promotion investment levels along with staffing levels and make-up of oversight groups.
--In the Field Strategy and Tactics - Analysis of sales functions' roles in co-promotions. From co-promotion leadership to in the field communication links and conflict resolution.
--Identifying and Converting Co-Promotion Opportunities - Analysis of business development's efforts in finding and winning co-promotion deals - from staffing and investment to strategy.
Companies Profiled in this Report Include:
--Merck & Co.
For more information visit http://www.researchandmarkets.com/reports/c39089
|Printer friendly Cite/link Email Feedback|
|Date:||Jul 5, 2006|
|Previous Article:||Toshiba Lighting & Technology Develops Small-Sized Ceramic Metal Halide Lamp.|
|Next Article:||Urinary Incontinence Therapeutics Market Expected To Be Worth Approximately $3.7 Billion By 2010.|